XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net income $ 10,207 $ 5,068
Adjustments to reconcile net income to net cash provided by operating activities:    
Net discount accretion (738) (664)
Depreciation and amortization expense 1,353 1,388
Provision for loan losses (1,000) 925
Share-based compensation 467 525
Gain on sales of loans originated for sale (1,320) (1,216)
Mortgage loans originated for sale (55,720) (20,851)
Proceeds from sales of loans originated for sale 56,959 23,185
Gain on sale of portfolio loans 0 (1,878)
Deferred income taxes (1,600) 1,024
Investment securities (gains) losses (145) 40
Income from life insurance (557) (540)
Increase in accrued interest receivable (143) (657)
Increase (decrease) in accrued interest payable and other liabilities 12,095 (352)
Other, net (3,225) (1,566)
Net cash provided by operating activities 16,633 4,431
Cash flows from investing activities    
Proceeds from sales of AFS securities 75,736 0
Maturities, repayments and calls of AFS securities 11,406 20,497
Purchases of AFS securities (29,233) (26,692)
Net redemptions of restricted investments in bank stocks 256 361
Net decrease in loans (64,634) (31,515)
Proceeds from sales of portfolio loans 0 21,618
Purchases of bank premises and equipment (156) (83)
Net cash used in investing activities (6,625) (15,814)
Cash flows from financing activities    
Net decrease in deposits 190,198 21,746
Net increase (decrease) in borrowings with original maturities less than 90 days 3,328 (65,716)
Proceeds from FHLB advances and other borrowings 0 99,977
Payments on FHLB advances and other borrowings (103) (40,098)
Dividends paid (2,004) (1,906)
Acquisition of treasury stock 0 (1,170)
Treasury shares repurchased for employee taxes associated with restricted stock vesting (514) (337)
Proceeds from issuance of employee stock purchase plan shares 74 61
Net cash provided by financing activities 190,979 12,557
Net increase in cash and cash equivalents 200,987 1,174
Cash and cash equivalents at beginning of period 125,258 55,963
Cash and cash equivalents at end of period 326,245 57,137
Cash paid during the period for:    
Interest 1,629 5,544
Supplemental schedule of noncash investing activities:    
Securities purchases not yet settled $ 11,699 $ 714